SOPs for BA-BE Studies V 2.0

To define the procedure for generating, assigning, and managing labels and barcodes for biological samples collected during Bioavailability/Bioequivalence (BA/BE) studies, ensuring sample traceability and data integrity.
Click to read the full article.

To describe the procedure for organizing and conducting Clinical Investigator’s Meetings (CIMs) in Bioavailability/Bioequivalence (BA/BE) studies to ensure protocol comprehension, role clarity, GCP compliance, and standardized procedures across all stakeholders.
Click to read the full article.

To establish a standardized and compliant procedure for managing regulatory inspections at clinical trial sites conducting Bioavailability/Bioequivalence (BA/BE) studies, ensuring full preparedness, transparency, and proper follow-up.
Click to read the full article.

To establish a consistent and regulatory-compliant procedure for maintaining Source Data Verification (SDV) logs in BA/BE studies to confirm data accuracy between source documents and case report forms (CRFs).
Click to read the full article.

To define the procedure for identifying, managing, and documenting deviations from the planned pharmacokinetic (PK) blood sampling schedule in bioavailability/bioequivalence (BA/BE) studies to ensure accurate bioanalytical interpretation and regulatory compliance.
Click to read the full article.

To define the procedure for ensuring uninterrupted power supply to freezers storing biological samples in BA/BE studies by implementing reliable backup systems to prevent sample degradation during power failures.
Click to read the full article.

To define a clear procedure for the identification, notification, impact assessment, and documentation of temperature excursions involving investigational products and biological samples in BA/BE studies.
Click to read the full article.

To define the procedure for preparing and executing a standardized Clinical Site Close-Out Checklist for bioavailability/bioequivalence (BA/BE) studies, ensuring all site activities are properly concluded and documented.
Click to read the full article.

To establish a procedure for compiling, maintaining, and archiving the Clinical Site Master File (CSMF) for each clinical trial site involved in bioavailability/bioequivalence (BA/BE) studies to ensure regulatory compliance and data traceability.
Click to read the full article.

To outline the procedures for hand hygiene and infection control to be followed by all clinical personnel involved in BA/BE studies to minimize risk of cross-contamination, maintain aseptic conditions, and protect both subjects and staff.
Click to read the full article.